Adverse events associated with mefloquine - Risk-benefit ratio must be taken into account

被引:2
作者
Dollow, S
机构
关键词
D O I
10.1136/bmj.313.7071.1553a
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1553 / 1553
页数:1
相关论文
共 5 条
[1]  
Barrett PJ, 1996, BRIT MED J, V313, P525, DOI 10.1136/bmj.313.7056.525
[2]   Neuropsychiatric reactions with mefloquine chemoprophylaxis [J].
Croft, AMJ ;
World, MJ .
LANCET, 1996, 347 (8997) :326-326
[3]   LONG-TERM MALARIA PROPHYLAXIS WITH WEEKLY MEFLOQUINE [J].
LOBEL, HO ;
MIANI, M ;
ENG, T ;
BERNARD, KW ;
HIGHTOWER, AW ;
CAMPBELL, CC .
LANCET, 1993, 341 (8849) :848-851
[4]   MEFLOQUINE COMPARED WITH OTHER MALARIA CHEMOPROPHYLACTIC REGIMENS IN TOURISTS VISITING EAST-AFRICA [J].
STEFFEN, R ;
FUCHS, E ;
SCHILDKNECHT, J ;
NAEF, U ;
FUNK, M ;
SCHLAGENHAUF, P ;
PHILLIPSHOWARD, P ;
NEVILL, C ;
STURCHLER, D .
LANCET, 1993, 341 (8856) :1299-1303
[5]  
1996, COMMUN DIS REP CDR W, V6, P287